Exploring the Activity Profile of TbrPDEB1 and hPDE4 Inhibitors Using Free Energy Perturbation

[Image: see text] Human African trypanosomiasis (HAT) is a neglected tropical disease caused by the parasite Trypanosoma brucei (T.b.). A validated target for the treatment of HAT is the parasitic T.b. cyclic nucleotide phosphodiesterase B1 (TbrPDEB1). Although nanomolar TbrPDEB1 inhibitors have bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Zara, Lorena, Moraca, Francesca, Van Muijlwijk-Koezen, Jacqueline E., Zarzycka, Barbara, Abel, Robert, de Esch, Iwan J. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190044/
https://www.ncbi.nlm.nih.gov/pubmed/35707144
http://dx.doi.org/10.1021/acsmedchemlett.1c00690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9190044/
https://www.ncbi.nlm.nih.gov/pubmed/35707144
http://dx.doi.org/10.1021/acsmedchemlett.1c00690

Ejemplares similares